Pulmonary Thromboembolism Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about Pulmonary Thromboembolism clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

The PERSEVERE Study

Pulmonary EmbolismPulmonary Thromboembolism
Inari Medical200 enrolled25 locationsNCT06588634
Recruiting
Not Applicable

Electrical Impedance Tomography for Assessment of Pulmonary Hypertension

Pulmonary HypertensionPulmonary Thromboembolisms
University of Sao Paulo General Hospital120 enrolled1 locationNCT07453017
Recruiting

Early Detection of CTEPH in Patients After APE

Chronic Pulmonary Thromboembolism
Institute of Health Information and Statistics of the Czech Republic500 enrolled10 locationsNCT06865326
Recruiting
Not Applicable

Functional Pulmonary Capillary Surface Area in BPA for CTEPH

Pulmonary ThromboembolismsHypertension, Pulmonary
Jewish General Hospital40 enrolled1 locationNCT05719415
Recruiting

Registry of Catheter Intervention in Pulmonary Embolism

Pulmonary EmbolismPulmonary ThromboembolismsPulmonary Embolism and Thrombosis+2 more
Hospital San Carlos, Madrid300 enrolled1 locationNCT06348459
Recruiting

Pulmonary Thromboembolism in Cancer Patients: Early Rule-out From the Emergency Department

Pulmonary Thromboembolisms
IRCCS Azienda Ospedaliero-Universitaria di Bologna500 enrolled1 locationNCT06761144
Recruiting

Personalized Anticoagulant Therapy for Pulmonary Thromboembolism

Pulmonary ThromboembolismsAnticoagulants; Increased
Xiangya Hospital of Central South University4,700 enrolled1 locationNCT06341231
Recruiting

The Prognostic Role and Diagnostic Efficacy of Exercise Right Heart Catheterization With a Simultaneous Echocardiography in Patients With Dyspnea on Exertion

Heart Failure With Preserved Ejection FractionChronic Pulmonary Thromboembolism (Disorder)
Samsung Medical Center400 enrolled1 locationNCT05490901